18 October 2017
News and Views
Links and Services
This week's issue of the Journal of the American Medical Association examines the effect of sulindac and erlotinib on duodenal polyps and cancer in patients with familial adenomatous polyposis.
Patients with familial adenomatous polyposis are at markedly increased risk for duodena
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors